Abstract
Objectives
This in vivo research investigated whether pulp treatments using formocresol for 7 days would cause mutagenic changes in children’s lymphocytes.
Materials and methods
The mutagenicity was tested in lymphocyte cultures established from the peripheral blood of children living in Brazil. The samples consisted of 2000 cells from teeth undergoing formocresol pulpotomies in which the formocresol pellet was sealed in the primary tooth for 7 days. It was removed on the seventh day, the base was placed, and the tooth was restored. Two venous blood samples (6–8 ml) were collected from each child; the first was prior to pulp therapy, and the second was 7 days later. Two thousand metaphases were analyzed. The level of significance adopted for the statistics was P < 0.05, and a random effects meta-analysis was performed combining this and two previous studies.
Results
There was no significant difference found in the metaphase analysis between the blood samples taken before and after the pulpotomy treatment (Wilcoxon signed rank test); however, the meta-analysis showed a significant difference between the combined studies.
Conclusions
This study did not reveal any mutagenic effects, but based on the combined meta-analysis, we recommend the careful use of formocresol.
Clinical relevance
This research helps to bring scientific evidence of the safe use of formocresol in deciduous pulpotomy treatments.
Similar content being viewed by others
References
American Academy of Pediatric Dentistry (A.A.P.D.). Guideline on pulp therapy for primary and immature permanent teeth. “http://www.aapd.org/media/Policies_Guidelines/G_Pulp.pdf”. Accessed 20 July 2017
Dunston B, Coll JA (2008) A survey of primary tooth pulp therapy as taught in US dental schools and practiced by diplomats of the American Board Of Pediatric Dentistry. Pediatr Dent 30(1):42–48
Buckley JP (1906) A rational treatment for putrescent pulps and their sequelae. Dental Cosmos 48:537–544
Buckley JP (1904) The chemistry of pulp decomposition with a rational treatment for this condition and its sequelae. Am Dent J 3:764–771
Roberts JF (1996) Treatment of vital and non-vital primary molar teeth by one-stage formocresol pulpotomy: clinical success and effect upon age at exfoliation. Int J Paediatr Dent 6(2):111–115
International Agency for Research on Cancer (IARC), Formaldehyde. IARC monographs on the evaluation of carcinogenic risks to humans. “http://www.monographs.iarc.fr/ENG/Classification/ClassificationAlphaOrder.pdf” . Accessed 20 July 2017
Strange DM, Seale NS, Nunn ME, Strange M (2001) Outcome formocresol/ZOE sub-base pulpotomies using alternative radiographic success criteria. Pediatr Dent 23(4):331–336
Morawa AP, Straffon LH, Han SS, Corpron RE (1975) Clinical evaluation of pulpotomies using dilute formocresol. J Dent Child 42(5):360–363
Coll JA (2008) Indirect pulp capping and primary teeth: is the primary tooth pulpotomy out of date? Pediatric Dent 30:230–236
Casas MJ, Kenny DJ, Judd PL, Johnson DH (2005) Do we still need formocresol in pediatric dentistry? J Can Dent Assoc 71(10):749–751
National Toxicology Program (2010) Final report on carcinogens background document for formaldehyde. Rep Carcinog Backgr Doc i:512
Fuks AB (2008) Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives. Pediatr Dent 30(3):211–219
Abuabara A, Crozeta BM, Baratto-Filho F (2012) Review of pulp therapy in primary teeth. RSBO 9:474–477
Zarzar PA, Rosenblatt A, Takahashi CS, Takeuchi PL, Costa Júnior LA (2003) Formocresol mutagenicity following primary tooth pulp therapy: an in vivo study. J Dent 31(7):479–485. https://doi.org/10.1016/S0300-5712(03)00087-3
Wesley DJ, Marshall FJ, Rosen S (1970) The quantification of formocresol as a root canal medicament. Oral Surg Oral Med Oral Pathol 29(4):603–612. https://doi.org/10.1016/0030-4220(70)90472-X
Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA (1960) Chromosome preparations of leucocytes cultured from human peripheral blood. Exp Cell Res 20(3):613–616. https://doi.org/10.1016/0014-4827(60)90138-5
Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Kirchner S, Lorge E, Morita T, Norppa H, Surrallés J, Vanhauwaert A, Wakata A (2003) Report from the in vitro micronucleus assay working group. Mutat Res 540(2):153–163. https://doi.org/10.1016/j.mrgentox.2003.07.005
Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG, Tice R, Waters MD, Aitio A (2000) IPCS guidelines for monitoring the genotoxic effect of carcinogens in humans. International Programme on Chemical Safety. Mutat Res 463(2):111–172. https://doi.org/10.1016/S1383-5742(00)00049-1
International Atomic Energy Agency (1986). Biological dosimetry: chromosomal aberrations analysis for dose assessment. Technical Report Series Number 260. Vienna
Cardoso L, Zembruski C, Fernandes DSC, Boff I, Pessin V (2005) Evaluation of prevalence of precocious losses of deciduous molars. Pesq Bras Odontoped Clin Integr 5:17–22
Milnes AR (2006) Persuasive evidence that formocresol use in pediatric dentistry is safe. J Can Dent Assoc 72(3):247–248
McClellan RO (1996) Reducing uncertainty in risk assessment by using specific knowledge to replace defaults options. Drug Metab Rev 28(1-2):149–179. https://doi.org/10.3109/03602539608993997
Ni Chaollai A, Monteiro J, Duggal MS (2009) The teaching management of the pulp in primary molars in Europe: a preliminary investigation in Ireland and the UK. Eur Arch Paediatr Dent 10(2):98–103. https://doi.org/10.1007/BF03321609
Leite AC, Rosenblatt A, Calixto MS, Silva CM, Santos N (2012) Genotoxic effect of formocresol pulp therapy of deciduous teeth. Mutat Res 30:93–97
Ranly DM (1985) Assessment of the systemic distribution and toxicity of formaldehyde following pulpotomy treatment: part one. ASDC J Dent Child 6:431–435
Marrazzini A, Betti C, Bernacchi F, Barrai I, Barale R (1994) Micronucleus test and metaphase analysis in mice exposed to known and suspected spindle poisons. Mutagenesis 9(6):505–515. https://doi.org/10.1093/mutage/9.6.505
Ribeiro-Silva A, Zucoloto S (2003) The p53 family: structural and functional aspects of p73 and p63. J Bras Patol Med Lab 39:179–184
Friedenson B (2011). Mutations in pathways depending on BRCA1 and BRCA2 may increase cancer risks from an environmental carcinogenic. Nat Proc. https://doi.org/10.1038/npre.2011.5669.1
Symington L, Gautier J (2011) Double-strand break and resection and repair pathway choice. Annu Rev Genet 45(1):247–271. https://doi.org/10.1146/annurev-genet-110410-132435
Jacobs A, Schar P (2012) DNA glycosylases: in DNA repair and beyond. Chromosoma 121(1):1–20. https://doi.org/10.1007/s00412-011-0347-4
Smaïl-Faugeron V. et al. (2014) Pulp treatment for extensive decal in primary teeth (review). Cochrane Database of Systematic Reviews 1–193
Hugar SM, Reddy R, Deshpande SD, Shigli A, Gokhale NS, Hugar SS (2017) In vivo comparative evaluation of mineral trioxide aggregate and formocresol pulpotomy in primary molars: a 60-month follow-up study. Contemp Clin Dent 8(1):122–127. https://doi.org/10.4103/ccd.ccd_849_16
Coll JA, Seale NS, Vargas K, Marghalani AA, Al Shamali S, Graham L (2017) Primary tooth vital pulp therapy: a systematic review and meta-analysis. Pediat Dent 39(1):16–123
Acknowledgments
The authors would like to thank the Brazilian Ministry of Education (Coordination for the Improvement of Higher Education Personnel, CAPES) for their support during the development of this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethical committee of Medical Center Fernando Figueira Institute (IMIP – Brazil – IRB 748/2006) approved the study.
Informed consent
For all participating children, parents and/or guardians provided written informed consent.
Rights and permissions
About this article
Cite this article
de Alencar Filho, A.V., dos Santos Junior, V.E., da Silva Calixto, M. et al. Evaluation of the genotoxic effects of formocresol application in vital pulp therapy of primary teeth: a clinical study and meta-analysis. Clin Oral Invest 22, 2553–2558 (2018). https://doi.org/10.1007/s00784-018-2352-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-018-2352-y